Pharmaron Beijing Balance Sheet Health
Financial Health criteria checks 6/6
Pharmaron Beijing has a total shareholder equity of CN¥14.0B and total debt of CN¥5.4B, which brings its debt-to-equity ratio to 38.7%. Its total assets and total liabilities are CN¥23.6B and CN¥9.5B respectively. Pharmaron Beijing's EBIT is CN¥1.5B making its interest coverage ratio -3.3. It has cash and short-term investments of CN¥2.6B.
Key information
38.7%
Debt to equity ratio
CN¥5.43b
Debt
| Interest coverage ratio | -3.3x |
| Cash | CN¥2.60b |
| Equity | CN¥14.03b |
| Total liabilities | CN¥9.54b |
| Total assets | CN¥23.57b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 17Q1's short term assets (CN¥7.1B) exceed its short term liabilities (CN¥4.2B).
Long Term Liabilities: 17Q1's short term assets (CN¥7.1B) exceed its long term liabilities (CN¥5.4B).
Debt to Equity History and Analysis
Debt Level: 17Q1's net debt to equity ratio (20.2%) is considered satisfactory.
Reducing Debt: 17Q1's debt to equity ratio has reduced from 48.6% to 38.7% over the past 5 years.
Debt Coverage: 17Q1's debt is well covered by operating cash flow (46%).
Interest Coverage: 17Q1 earns more interest than it pays, so coverage of interest payments is not a concern.